14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
FHLC vs FIDU: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Fidelity MSCI Health Care Index ETF (FHLC) is the stronger overall head-to-head candidate over Fidelity MSCI Industrials Index ETF (FIDU) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FHLC carries a Unified Composite Score of 41.6/100 (SELL) at $89.37 (N/M Forward P/E, N/A operating margin), whereas FIDU carries 43.5/100 (HOLD) at $87.81 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While FIDU currently prints a higher short-term Unified Composite Score (43.5/100 HOLD vs. FHLC 41.6/100 SELL), FHLC captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: FHLC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 60.2); meanwhile FIDU is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FHLC vs FIDU. Trailing 12-month operating profitability (FHLC N/A vs FIDU N/A) and valuation multiples (FHLC N/M vs FIDU N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ FHLC vs FIDU Key Questions & Quantitative Answers
As of Nov 16, 2026, Fidelity MSCI Health Care Index ETF (FHLC) is the stronger overall head-to-head candidate over Fidelity MSCI Industrials Index ETF (FIDU) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FHLC carries a Unified Composite Score of 41.6/100 (SELL) at $89.37 (N/M Forward P/E, N/A operating margin), whereas FIDU carries 43.5/100 (HOLD) at $87.81 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While FIDU currently prints a higher short-term Unified Composite Score (43.5/100 HOLD vs. FHLC 41.6/100 SELL), FHLC captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: FHLC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 60.2); meanwhile FIDU is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
FHLC and FIDU split Growth & Scale metrics: FHLC posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with FIDU at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, FHLC generates N/A in USD-normalized revenue versus N/A for FIDU. In operating R&D and SG&A reinvestment, FHLC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FIDU.
FHLC and FIDU trade at balanced relative valuation multiples. FHLC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas FIDU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FHLC (N/A ROE) versus FIDU (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, FHLC carries 17.7% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.36β · 21% Vol realized risk). By comparison, FIDU carries 18.7% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 26% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.